# US 2024/0199595 A1 · Novel processes for preparation of soluble guanylate cyclase stimulators

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0199595 A1
- Document ID: US20240199595A1
- Status: Published application
- Kind: A1
- Application number: 18/385,025
- Filed: 2023-10-30
- Published: 2024-06-20
- Earliest claimed: 2016-07-07
- Assignees: Cyclerion Therapeutics, Inc.
- Applicants: Cyclerion Therapeutics, Inc.
- Inventors: Song Xue; Vishnu Vardhan Reddy Karnati; Robert C. Livingston; Timothy Claude Barden; Wayne C. Schairer
- Web page: https://patentgrep.com/patent/US20240199595A1

## CPC

- C07D 413/14: containing three or more hetero rings
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 209/00: Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C 231/12: by reactions not involving the formation of carboxamide groups
- C07C 231/14: by formation of carboxamide groups together with reactions not involving the carboxamide groups
- C07C 237/06: having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07D 261/08: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 261/18: Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
- C07D 263/34: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D 413/04: directly linked by a ring-member-to-ring-member bond
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The present disclosure relates to novel processes for the preparation of compounds useful as stimulators of soluble guanylate cyclase (sGC). These processes are amenable to large scale preparation and produce stable 3-(2-pyrimidinyl)pyrazoles of Formula (I), including Compound (I), Compound (IA) and Compound (IB), in high purity and yields. The present invention has the additional advantage of facile reaction conditions, amenable to scale up for large scale manufacturing. The disclosure also provides novel intermediates useful in the preparation of said compounds.

## Claims

### Claim at position 1

1-46. (canceled)

### Claim 47

A compound selected from:

### Claim 48

A compound selected from:
a 1:1 salt of (18A) with (D)-malic acid:
and
a 1:1 salt of (18B) and (L)-malic acid:
